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INTRODUCTION
Pain initiated or caused by a primary lesion or dysfunction in the nervous system is defined 
as neuropathic pain [1]. It results from direct injury to nerves in the peripheral or central 
nervous system and is associated with several clinical symptoms. Neuropathic pain treatment 
is extremely difficult, as it is a very complex disease, involving several molecular pathways 
[1]. Excitatory or inhibitory pathways controlling neuropathic pain development show altered 
gene expression, caused by peripheral nerve injury [2, 3]. This study used several 
experimental pain models to demonstrate the occurrence of programmed cell death in the 
centers controlling pain induction and maintenance, such as spinal cord and pre-frontal 
cortex. 
RESULTS AND CONCLUSIONS
We combined behavioural, molecular and morphological 
approaches to assess the involvement of bcl-2 gene family and 
caspases in neuropathic pain. Chronic constriction injury (CCI) 
and spared nerve injury (SNI) of rodent sciatic nerve induced the 
appearance of pain-like behaviours, such as hyperalgesia and 
allodynia. An early (2-3 days post-CCI) apoptosis appeared in the 
spinal cord neurons as the pro-apoptotic bax gene increased 
(320±19%). The incidence of apoptosis appeared to be limited to 
the first few days following nerve injury. Subsequently, increased 
expression of anti-apoptotic bcl-2 family genes may inhibit further 
neuron loss. SNI triggered apoptotic pathway and caspases 
activation in pre-frontal cortex 7, 14, and 21 days post-injury. 
Among the time-points analyzed, RT-PCR analysis showed 
increased expression of the bax/bcl-2 ratio (40±2%), bid (16±2%), 
caspase-1 (84±3%), caspase-8 (53±6%), caspase-9 (25±6%), 
caspase-12 (58±2%), TNF (32±2%) genes in the cortex by 7 days 
post-injury. Western blot analysis showed increased active 
Caspase-3 protein levels in the cortex at 3, 7, and 14 days post-
surgery. This study shows that apoptotic genes could be an useful 
pharmacological target in neuropathic pain controlling.
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MATERIALS AND METHODS
Surgery and behavioural tests 
Mononeuropathy was induced by spared nerve injury (SNI) and/or chronic constriction injury 
(CCI). Mice were anaesthetized with sodium pentobarbital, the sciatic nerve was exposed at 
mid-thigh and freed of connective tissue, and the common peroneal and the tibial nerves were 
tight-ligated with 5.0 silk (for CCI), and sectioned distal to the ligation leaving the remaining 
sural nerve intact (for SNI). Sham mice were anaesthetised and the sciatic nerve exposed, but 
no ligatures or cuts were placed. 
Thermal hyperalgesia was evaluated by using a Plantar Test Apparatus. The latency of 
nociceptive reaction was measured in seconds under basal conditions and at 3, 7, 14 and 21 
days after sham operation or sciatic nerve injury. 
Mechanical allodynia was measured with a Dynamic Plantar Anesthesiometer, which applies a 
linearly increasing mechanical force to the dorsum of the mice hind paw. 
RNA extraction and RT-PCR
Total RNA was extracted from homogenized whole cortex or spinal cord using an RNA Trizol-
Reagent. The total RNA concentration was determined by UV spectrophotometer. The mRNA 
levels of the genes under analysis were measured by RT-PCR amplification. Sequences for 
the rat mRNAs from GeneBank were used to design primer pairs for RT-PCRs. Each RT-PCR 
was repeated at least four times. A semiquantitative analysis of mRNA levels was carried out 
by the “ GEL DOC 1000 UV SYSTEM”  (Bio-Rad, Hercules, CA). The measured mRNA 
levels were normalised with respect to hypoxanthine-guanine phosphoribosyltransferase 
(HPRT), chosen as housekeeping gene, and the gene expression values were expressed as 
arbitrary units  ± SE.
Western blotting
For the protein extraction, the cortex or the spinal cord was minced into small pieces with a 
blender, then was suspended in lysis buffer. The tissue was sonicated in ice. Sonication was 
carried out for two cycles of 15 s each. Each sample was loaded, electrophoresed in a  12% 
polyacrylamide gel and electroblotted onto a nitrocellulose membrane. Primary antibodies to 
detect casp-3 were used at 1:500. Immunoreactive signals were detected with a horseradish 
peroxidase-conjugated secondary antibody and reacted with an ECL system. Protein levels 
were normalised with respect to the signal obtained with anti-actin monoclonal antibodies.
Fig. 1. Changes in the genic expressions in CCI-neuropathic mice. The graphs indicate the 
percentage of gene expression ratio. L: CCI mice. C: control mice. The numbers indicate the 
days of the sciatic nerve ligature. °p<0.05 vs C.
Fig. 2. Changes in the genic expressions in SNI-neuropathic mice. 
The graphs indicate the percentage of gene expression ratio. L: SNI 
mice with nerve ligature. °p<0.05 vs C.
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Fig. 3. Changes in the Caspase-3 protein levels in 
SNI-neuropathic mice. The graphs indicate the 
percentage of Caspase-3 active form. L: SNI mice 
with nerve ligature. °p<0.05 vs C.
°
°
°
°
°
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
08
.1
54
9.
1 
: P
os
te
d 
30
 J
an
 2
00
8
